Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada
Evaluating life expectancy and mortality of HIV-positive individuals initiating combination ART across Canada
View PublicationFilter By:
Opioid use and risk of liver fibrosis in HIV/hepatitis C virus‐coinfected patients in Canada
Investigating opioid use in an HIV/HCV‐coinfected population in Canada and the association between opioid use and liver fibrosis
View PublicationCD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV‐positive patients
A review focusing on the relevance of the CD4:CD8 ratio on clinical outcomes, immune dysfunction and HIV reservoir size in long‐term treated patients
View PublicationNef promotes evasion of human immunodeficiency virus type 1-infected cells from the CTLA-4-mediated inhibition of T-cell activation
Investigating mechanisms by which HIV-1 modulates CTLA-4 expression to establish productive viral infection in CD4+ T cells
View PublicationChanges in quality of life, healthcare use, and substance use in HIV/hepatitis C coinfected patients after hepatitis C therapy: a prospective cohort study
Examining changes in health-related quality of life, health care and substance use, and overall mortality after treatment for HCV coinfection
View PublicationImpaired Th17 polarization of phenotypically naive CD4+ T-cells during chronic HIV-1 infection and potential restoration with early ART
Investigating the Th17 polarization potential of naive-like CD4+ T-cells, depletion of Th17-commited subsets during HIV pathogenesis, and Th17 restoration in response to ART
View PublicationFavourable IFNL3 Genotypes Are Associated with Spontaneous Clearance and Are Differentially Distributed in Aboriginals in Canadian HIV-Hepatitis C Co-Infected Individuals
Testing the association of spontaneous clearance and three single nucleotide polymorphisms near the Interferon-lambda 3 gene
View PublicationEffect of Intercurrent Infections and Vaccinations on Immune and Inflammatory Biomarkers Among Human Immunodeficiency Virus-Infected Adults on Suppressive Antiretroviral Therapy
Using generalized estimating equations to quantify the impact of recent vaccination or intercurrent infections on immune and inflammatory biomarkers among HIV-infected adults
View PublicationRapid human immunodeficiency virus disease progression is associated with human leukocyte antigen-B homozygocity and human leukocyte antigen-B51 in a cohort from Manitoba, Canada
Determining the role of HLA-B allele frequency on rapid HIV disease progression
View PublicationHIV and the Gut Microbiota, Partners in Crime: Breaking the Vicious Cycle to Unearth New Therapeutic Targets
Reviewing the changes in gut microbiota during HIV infection and the factors that modulate gut microbiota in relation to inflammation in HIV patients
View Publication